These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25419568)

  • 1. Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.
    Skrbo N; Hjortland GO; Kristian A; Holm R; Nord S; Prasmickaite L; Engebraaten O; Mælandsmo GM; Sørlie T; Andersen K
    PLoS One; 2014; 9(11):e113278. PubMed ID: 25419568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis on clone in vitro and tumorigenic capacity in vivo of different subsets cells from the MCF-7 human breast cancer cell line].
    Li Z; Liu CP; He YL; Tian Y; Huang T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):547-9. PubMed ID: 18798490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD24(+) cells fuel rapid tumor growth and display high metastatic capacity.
    Rostoker R; Abelson S; Genkin I; Ben-Shmuel S; Sachidanandam R; Scheinman EJ; Bitton-Worms K; Orr ZS; Caspi A; Tzukerman M; LeRoith D
    Breast Cancer Res; 2015 Jun; 17(1):78. PubMed ID: 26040280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity.
    Kim J; Villadsen R; Sørlie T; Fogh L; Grønlund SZ; Fridriksdottir AJ; Kuhn I; Rank F; Wielenga VT; Solvang H; Edwards PA; Børresen-Dale AL; Rønnov-Jessen L; Bissell MJ; Petersen OW
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6124-9. PubMed ID: 22454501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
    Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
    Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.
    Wang M; Xiao J; Shen M; Yahong Y; Tian R; Zhu F; Jiang J; Du Z; Hu J; Liu W; Qin R
    Int J Cancer; 2011 Jan; 128(1):72-81. PubMed ID: 20232394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topotecan-induced ABCG2 expression in MCF-7 cells is associated with decreased CD24 and EpCAM expression and a loss of tumorigenicity.
    Huber S; Wege AK; Bernhardt G; Buschauer A; Brockhoff G
    Cytometry A; 2015 Aug; 87(8):707-16. PubMed ID: 25892097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors.
    Cho RW; Wang X; Diehn M; Shedden K; Chen GY; Sherlock G; Gurney A; Lewicki J; Clarke MF
    Stem Cells; 2008 Feb; 26(2):364-71. PubMed ID: 17975224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
    Farnie G; Sotgia F; Lisanti MP
    Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
    Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
    Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EpCAM expression in breast cancer cells is associated with enhanced bone metastasis formation.
    Hiraga T; Ito S; Nakamura H
    Int J Cancer; 2016 Apr; 138(7):1698-708. PubMed ID: 26576938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
    Shao J; Fan W; Ma B; Wu Y
    Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
    Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H
    J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.
    Rappa G; Lorico A
    Exp Cell Res; 2010 May; 316(9):1576-86. PubMed ID: 20074564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential.
    Mosoyan G; Nagi C; Marukian S; Teixeira A; Simonian A; Resnick-Silverman L; DiFeo A; Johnston D; Reynolds SR; Roses DF; Mosoian A
    PLoS One; 2013; 8(1):e55145. PubMed ID: 23372829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer.
    Appaiah H; Bhat-Nakshatri P; Mehta R; Thorat M; Badve S; Nakshatri H
    Cancer Biol Ther; 2010 Sep; 10(6):600-14. PubMed ID: 20603605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer.
    Wu J; Crowe DL
    Oncol Rep; 2015 Jul; 34(1):455-60. PubMed ID: 25998860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
    Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
    Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.